Pages that link to "Item:Q2194989"

The following pages link to Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations (Q2194989):

Displaying 50 items.

• Natural killer cells recruitment in oncolytic virotherapy: a mathematical model (Q2035789) (← links)
• Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling (Q2068758) (← links)
• A multi-drug pharmacokinectic optimal control approach in cancer chemotherapy (Q2082249) (← links)
• Can the Kuznetsov model replicate and predict cancer growth in humans? (Q2082825) (← links)
• Mathematical modeling of tumor growth and treatment: triple negative breast cancer (Q2095683) (← links)
• PDE modeling of bladder cancer treatment using BCG immunotherapy (Q2097382) (← links)
• Analysis of stochastic dynamics of tumor with drug interventions (Q2098727) (← links)
• Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach (Q2120664) (← links)
• Comparative study for optimal control nonlinear variable-order fractional tumor model (Q2120668) (← links)
• Parameter estimation and sensitivity analysis for a model of tumor-immune interaction in the presence of immunotherapy and chemotherapy (Q2122017) (← links)
• The stability analysis of tumor-immune responses to chemotherapy system driven by Gaussian colored noises (Q2128125) (← links)
• The impact of distributed time delay in a tumor-immune interaction system (Q2128278) (← links)
• Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach (Q2131714) (← links)
• Is the Allee effect relevant in cancer evolution and therapy? (Q2132320) (← links)
• Noise and delay enhanced stability in tumor-immune responses to chemotherapy system (Q2137512) (← links)
• A deterministic and stochastic model for the system dynamics of tumor-immune responses to chemotherapy (Q2150394) (← links)
• Dynamic analysis of a model on tumor-immune system with regulation of PD-1/PD-L1 and stimulation delay of tumor antigen (Q2156325) (← links)
• Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy (Q2157844) (← links)
• Optimal control with isoperimetric constraint for chemotherapy of tumors (Q2170964) (← links)
• A mathematical model of chemotherapy with variable infusion (Q2175694) (← links)
• Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions (Q2176049) (← links)
• Existence of periodic solution for a tumor growth model with vaccine interaction (Q2179271) (← links)
• Chemotherapy and immunotherapy for tumors: a study of quadratic optimal control (Q2187010) (← links)
• Optimal control of inhibiting tumor, new approach to sufficient \(\varepsilon\)-optimality and numerical computation (Q2194798) (← links)
• Mathematical modelling of the inhibitory role of regulatory T cells in tumor immune response (Q2205364) (← links)
• What mathematical models can or cannot do in glioma description and understanding (Q2206309) (← links)
• Global dynamics of a breast cancer competition model (Q2210359) (← links)
• Optimization of interleukin-21 immunotherapeutic strategies (Q2211591) (← links)
• Modeling the effect of immunotherapies on human castration-resistant prostate cancer (Q2225975) (← links)
• Modelling pulsed immunotherapy of tumour-immune interaction (Q2228589) (← links)
• Chemoimmunotherapy for the treatment of prostate cancer: insights from mathematical modelling (Q2241785) (← links)
• An investigation on Monod-Haldane immune response based tumor-effector-interleukin-2 interactions with treatments (Q2279628) (← links)
• Mathematical modeling, analysis, and simulation of tumor dynamics with drug interventions (Q2283759) (← links)
• Bifurcation analyses and hormetic effects of a discrete-time tumor model (Q2286144) (← links)
• Targeting the quiescent cells in cancer chemotherapy treatment: is it enough? (Q2290768) (← links)
• Effects of mutations and immunogenicity on outcomes of anti-cancer therapies for secondary lesions (Q2328483) (← links)
• Dynamics of breast cancer under different rates of chemoradiotherapy (Q2332552) (← links)
• Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control (Q2335463) (← links)
• Dynamics of a tumor-immune model considering targeted chemotherapy (Q2410539) (← links)
• A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer (Q2413866) (← links)
• Iterative method for estimating the robust domains of attraction of non-linear systems: application to cancer chemotherapy model with parametric uncertainties (Q2415117) (← links)
• Mathematical modeling on helper T cells in a tumor immune system (Q2438841) (← links)
• Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls (Q2455569) (← links)
• Avoiding healthy cells extinction in a cancer model (Q2632759) (← links)
• A mathematical model for pancreatic cancer growth and treatments (Q2632820) (← links)
• Implementation of fractional optimal control problems in real-world applications (Q2660641) (← links)
• Modeling CAR T-cell therapy with patient preconditioning (Q2662113) (← links)
• Mathematical model of tumour spheroid experiments with real-time cell cycle imaging (Q2662116) (← links)
• Analysis of tumor cells in the absence and presence of chemotherapeutic treatment: the case of Caputo-Fabrizio time fractional derivative (Q2666213) (← links)
• A Mathematical Model of Gene Therapy for the Treatment of Cancer (Q2820390) (← links)